EMR (NYSE: EMR) insider plans Form 144 sale of 4,773 shares

Rhea-AI Filing Summary

EMR has a planned insider sale under Rule 144. The notice covers the proposed sale of 4,773 shares of common stock, with an aggregate market value of 640,000. These shares are part of 1,500,000 shares outstanding and are to be sold through Merrill Lynch on or about 12/01/2025 on the NYSE. The seller originally acquired the shares on 02/01/2016 as a stock award from the issuer, described as compensation.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 1033 Skokie Blvd. Suite 500 Northbrook IL 60062	4773	640000	1500000	12/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/01/2016	stock award	Issuer			4773	02/01/2016	compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does EMR's latest Form 144 filing disclose?

The Form 144 filing for EMR discloses a planned sale of 4,773 shares of common stock with an aggregate market value of 640,000 through Merrill Lynch on or about 12/01/2025.

How many EMR shares are covered by the Form 144 notice and what is their value?

The notice covers 4,773 EMR common shares with an aggregate market value of 640,000, compared with 1,500,000 shares outstanding for the issuer.

When and how were the EMR shares in this Form 144 acquired?

The 4,773 EMR shares were acquired on 02/01/2016 as a stock award from the issuer, with the nature of payment listed as compensation.

Which broker will handle the EMR Form 144 share sale and on which exchange?

The planned sale of 4,773 EMR common shares will be handled by Merrill Lynch, with the shares listed for trading on the NYSE.

What does the Form 144 representation say about material information for EMR?

The person for whose account the EMR securities are to be sold represents that they do not know any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed.